Pasireotide Subcutaneous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Pasireotide Subcutaneous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Subcutaneous-Pneumococcal 13-valent conjugate vaccine
- Pasireotide Subcutaneous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Pasireotide Subcutaneous-Pneumococcal Conjugate Vaccine (13-Valent)
- Pasireotide Subcutaneous-Pneumococcal Conjugate Vaccine (7-Valent)
- Pasireotide Subcutaneous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Pasireotide Subcutaneous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Patanase
- Pms-Sodium Polystyrene Sulfonate-Patiromer
- Pms-Sodium Polystyrene Sulfonate-Patiromer Sorbitex Calcium
- Pms-Sodium Polystyrene Sulfonate-Pavacot
- Pms-Sodium Polystyrene Sulfonate-Paxil
- Pms-Sodium Polystyrene Sulfonate-Paxil (Paroxetine Suspension)